Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?

J Natl Compr Canc Netw. 2018 Aug;16(8):927-932. doi: 10.6004/jnccn.2018.7057.
No abstract available

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Evidence-Based Medicine / methods
  • Evidence-Based Medicine / standards
  • HIV / drug effects
  • HIV / isolation & purification
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • Humans
  • Medical Oncology / methods
  • Medical Oncology / standards
  • Neoplasms / drug therapy*
  • Neoplasms / immunology
  • Neoplasms / virology
  • Observational Studies as Topic
  • Practice Guidelines as Topic*
  • Randomized Controlled Trials as Topic
  • Time Factors

Substances

  • Anti-HIV Agents
  • Antineoplastic Agents